News
Zacks Small Cap Research on MSN49m
PYPD: Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent BenefitsPYPD PolyPid Ltd. (NASDAQ:PYPD) is a late clinical stage biopharma company focused on developing locally administered, prolonged-release therapeutics using its proprietary Polymer-Lipid Encapsulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback